Orthofix Medical Stock Analysis

OFIX Stock  USD 18.87  0.14  0.75%   
Orthofix Medical is overvalued with Real Value of 15.28 and Target Price of 21.17. The main objective of Orthofix Medical stock analysis is to determine its intrinsic value, which is an estimate of what Orthofix Medical is worth, separate from its market price. There are two main types of Orthofix Medical's stock analysis: fundamental analysis and technical analysis.
The Orthofix Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Orthofix Medical is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Orthofix Stock trading window is adjusted to America/New York timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Orthofix Stock Analysis Notes

About 92.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthofix Medical has Price/Earnings To Growth (PEG) ratio of 0.33. The entity recorded a loss per share of 3.14. The firm had not issued any dividends in recent years. Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Orthofix Intl operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1087 people. To find out more about Orthofix Medical contact Massimo Calafiore at 214 937 2000 or learn more at https://www.orthofix.com.

Orthofix Medical Quarterly Total Revenue

196.61 Million

Orthofix Medical Investment Alerts

The company reported the previous year's revenue of 746.64 M. Net Loss for the year was (151.4 M) with profit before overhead, payroll, taxes, and interest of 337.17 M.
Orthofix Medical currently holds about 59.54 M in cash with (45.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98.
Over 92.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Orthofix Medical Shares Pass Above 200-Day Moving Average - Heres Why - MarketBeat

Orthofix Medical Upcoming and Recent Events

Earnings reports are used by Orthofix Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Orthofix Largest EPS Surprises

Earnings surprises can significantly impact Orthofix Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1996-07-25
1996-06-300.060.05-0.0116 
2022-08-05
2022-06-300.10.08-0.0220 
1997-10-27
1997-09-300.110.130.0218 
View All Earnings Estimates

Orthofix Medical Environmental, Social, and Governance (ESG) Scores

Orthofix Medical's ESG score is a quantitative measure that evaluates Orthofix Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Orthofix Medical's operations that may have significant financial implications and affect Orthofix Medical's stock price as well as guide investors towards more socially responsible investments.

Orthofix Medical Thematic Classifications

In addition to having Orthofix Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Idea
Obamacare
Companies that count on Obamacare to take off
Medical Equipment Idea
Medical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Orthofix Stock Institutional Investors

Shares
Geode Capital Management, Llc2024-06-30
827.6 K
Emerald Advisers, Llc2024-09-30
732.7 K
Dimensional Fund Advisors, Inc.2024-09-30
500.3 K
Awm Investment Company Inc2024-06-30
449.5 K
Tejara Capital Ltd2024-06-30
434.7 K
Millennium Management Llc2024-06-30
392.8 K
Emerald Mutual Fund Advisers Trust2024-09-30
372.1 K
Northern Trust Corp2024-09-30
338.3 K
Citadel Advisors Llc2024-06-30
331.9 K
Morgan Stanley - Brokerage Accounts2024-06-30
M
Armistice Capital, Llc2024-06-30
3.8 M
Note, although Orthofix Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Orthofix Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 721.1 M.

Orthofix Profitablity

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.25)(0.23)
Return On Capital Employed(0.18)(0.17)
Return On Assets(0.16)(0.16)
Return On Equity(0.25)(0.24)

Management Efficiency

Orthofix Medical has return on total asset (ROA) of (0.0237) % which means that it has lost $0.0237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2086) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.23 in 2024. Return On Capital Employed is likely to rise to -0.17 in 2024. At this time, Orthofix Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 530.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 21.1 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 16.30  11.27 
Tangible Book Value Per Share 7.80  4.61 
Enterprise Value Over EBITDA(6.80)(6.46)
Price Book Value Ratio 0.83  0.79 
Enterprise Value Multiple(6.80)(6.46)
Price Fair Value 0.83  0.79 
Enterprise Value591.6 M441.2 M
The operational strategies employed by Orthofix Medical management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin
(0.09)
Profit Margin
(0.15)
Beta
1.053
Return On Assets
(0.02)
Return On Equity
(0.21)

Technical Drivers

As of the 21st of November, Orthofix Medical holds the Semi Deviation of 2.02, coefficient of variation of 982.54, and Risk Adjusted Performance of 0.0835. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orthofix Medical, as well as the relationship between them.

Orthofix Medical Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Orthofix Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Orthofix Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Orthofix Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthofix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthofix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthofix Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Orthofix Medical Outstanding Bonds

Orthofix Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orthofix Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orthofix bonds can be classified according to their maturity, which is the date when Orthofix Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Orthofix Medical Predictive Daily Indicators

Orthofix Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Orthofix Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Orthofix Medical Corporate Filings

13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
8th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
19th of August 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
15th of August 2024
Other Reports
ViewVerify
8K
6th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
15th of July 2024
Other Reports
ViewVerify

Orthofix Medical Forecast Models

Orthofix Medical's time-series forecasting models are one of many Orthofix Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orthofix Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Orthofix Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Orthofix Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orthofix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orthofix Medical. By using and applying Orthofix Stock analysis, traders can create a robust methodology for identifying Orthofix entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.20)(0.19)
Operating Profit Margin(0.19)(0.18)
Net Loss(0.20)(0.19)
Gross Profit Margin 0.65  0.59 

Current Orthofix Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Orthofix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Orthofix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
21.17Buy5Odds
Orthofix Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Orthofix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Orthofix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Orthofix Medical, talking to its executives and customers, or listening to Orthofix conference calls.
Orthofix Analyst Advice Details

Orthofix Stock Analysis Indicators

Orthofix Medical stock analysis indicators help investors evaluate how Orthofix Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Orthofix Medical shares will generate the highest return on investment. By understating and applying Orthofix Medical stock analysis, traders can identify Orthofix Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow50.7 M
Long Term Debt93.1 M
Common Stock Shares Outstanding36.7 M
Total Stockholder Equity598.7 M
Tax Provision2.7 M
Property Plant And Equipment Net159.1 M
Cash And Short Term Investments37.8 M
Cash37.8 M
Accounts Payable58.4 M
Net Debt96.4 M
50 Day M A16.5502
Total Current Liabilities165.2 M
Other Operating Expenses885.8 M
Non Current Assets Total504.9 M
Forward Price Earnings20.0401
Non Currrent Assets Other33.4 M
Stock Based Compensation35.7 M

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.